DDX41 and COVID-19: When stratifying the total cohort of COVID-19 patients for presence of aIFN-Abs, we noted higher degrees of mortality (Figure 1C) whereas other patient characteristics, including age, sex, comorbidity, and body mass index were comparable between patients with (aIFNpos) and without (aIFNneg) autoantibodies (Supplementary Table 1).